← Leaderboards
Ari Grinspan
Icahn School Of Medicine At Mount Sinai
$500,240
Attributed
$1,000,480
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $338K · FY2022–24$500K$375K$250K$125K$0
'22
'23
'24
Funding mix
By agency
NIH$1,000,480 · 1
By mechanism
R01$1,000,480 · 1
Top collaborators
- Jeremiah James Faith3 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Rita Z Goldstein$21,338,452
- Jeremiah James Faith$16,695,707
- Miriam Merad$28,468,631
- Nathan E Goldstein$9,630,744
- Xiaosi Gu$7,980,067
Others in their field
Other Rising Stars on “Design”
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Jeffrey Leintz · National Opinion Research Center$38,969,238
- Rhea Coler · Seattle Children'S Hospital$35,184,139
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Sabrina Paganoni · Massachusetts General Hospital$30,895,527
Research focus
DesignAdverse EventActive ComparatorAntibioticsAntimicrobialBacteriaAftercareBasic ScienceBiobankBiological Response Modifier TherapyCessation Of LifeClinical ApplicationClinical CareClinical TrialsClostridium DifficileCollectionCommunitiesComparative EfficacyComplexCost EffectiveCoupledDensityDependenceDiarrhea
Grant awards (3)
Comparison of defined live biotherapeutic product and fecal microbiota transplantation for treatment of recurrent Clostridioides difficile infection$324,480
R01 · FY2024 · DK
Comparison of defined live biotherapeutic product and fecal microbiota transplantation for treatment of recurrent Clostridioides difficile infection$338,000
R01 · FY2023 · DK
Comparison of defined live biotherapeutic product and fecal microbiota transplantation for treatment of recurrent Clostridioides difficile infection$338,000
R01 · FY2022 · DK